Global Intelligent Nebulizers Market Size, Trends & Analysis - Forecasts to 2026 By Component (Nebulizer Device, Associated App and Consumables), By Type of Patients (Adult and Pediatric Patients), By End-User (Hospitals, Emergency Centers and Home Healthcare Settings), End-User Landscape, Company Market Share Analysis, and Competitor Analysis
To help treat or manage asthma, chronic respiratory diseases like bronchitis, cold, cough, and sore throat, among others a nebulizer is prescribed which converts the liquid medicine into a mist which is then inhaled by the patient/user. The device includes an inhaler or the mouthpiece along with differently sized masks along with the nebulizing machine.
These nebulizers are electrical or battery-operated. The three major types of nebulizers are namely jet, ultrasonic, and mesh nebulizers. The jet nebulizers help to convert the liquid medicine into an aerosol which is the tiny particles of the medication. The ultrasonic nebulizers convert the aerosols with the help of high-frequency vibration which produces larger particles of the medications. The mesh nebulizers help to create aerosols by simply allowing the liquid medication to pass through a mesh attached to the inhaler. These devices are highly portable in size making it easier for the patients to address asthma despite any location. The market also has large-sized nebulizers that are a benchtop version of the portable one and is mounted to the wall. Such nebulizers are found mostly in hospitals and clinics, whereas portable ones are for the home healthcare settings.
The gadget is intended to use aerosolized fluid drugs for inward breath by the patient. The embedded medicine is apportioned in a mist for comfortable treatment. This fine mist permits meds to straightforwardly arrive at territories of the body for the best treatment, without going through the stomach-digestive tract part of the body. Hence, out of the three types of nebulizers, the mesh nebulizers offer variation in the rate or intensity of the mist formation to adjust as per the type of medication dosage, type of disease, and type of patient. The market has further witnessed the advancements made to the portable mesh nebulizer by launching intelligent or smart nebulizers. Such types can sync with the designated app to monitor the number of doses, alarm management if the dose is missed or not inhaled properly and patient data maintenance useful for the doctors. Such nebulizers have been designed for both adults as well as Pediatric patients. Another technical advancement made to the nebulizer is the incorporation of the IAD technology. This IAD technology senses the patient’s breathing to deliver medication only on inhaling the prescribed drug and eventually eliminating the cough/ congestion. With advantages over the benchtop nebulizers such as portability, battery-operated, one-button operated, less noisy, more powerful than the latter one, the market has seen a rise in the value for intelligent mesh nebulizers.
Increasing prevalence of COPD, cystic fibrosis especially in pediatric patients, and asthma across the developed and developing countries, high portability of the mesh nebulizers, the capability to track and manage the drug dosage data along with patient data, rising consumer spending on portable medical devices in developed countries, favorable reimbursement scenarios associated with medical equipment and instruments and rising awareness of patient-centric treatment (bed-side treatment) will help the market grow exponentially. Asthma is one of the major drivers for this device to be used frequently both by the adult as well as young children. As per the 2019 data released by CDC (Centre for Disease Control and Prevention), 1 in every 13 individuals is associated with asthma or some form of chronic lung disease. The US is home to more than 25 million Asthma patients out of which 8.4% of the patients are children and 7.7% are young adults. Globally, more than 339 million people are living with Asthma making this segment the most promising segment in the portable medical device industry.
Based on components, the market can be segmented into the nebulizing device, the associated software/ app, and the consumables. However, owing to the increasing global number of Asthma patients every year, the market for the nebulizing device will be the largest. As per a report published by the WHO in 2016, deaths due to Asthma attack was around 417,918 globally with 24.8 million living with the condition.
Based on the type of the patient, the market can be classified into adult and pediatric patients. However, considering that lung diseases and asthma are more chronic in children than in adults, the market for pediatric patients will be growing faster than for the latter one. Asthma has killed more children than adult individuals with more than 3 million children living with Asthma since 2017. The US is home to more than 25 million Asthma patients out of which 8.4% of the patients are children and 7.7% are young adults.
Based on the end-user type the market for nebulizers can be classified into hospitals, emergency centers, and home healthcare settings. However owing to the features of portability and patient-friendly usage, the market for home healthcare setting is ought to be the fastest as well as the largest market segment from 2021 to 2026
As per the geographical analysis, the market of intelligent nebulizers can be classified into the Asia Pacific (India, China, Japan, Malaysia, Singapore, and the Rest of Asia Pacific), North America (the US, Canada, and Mexico), Middle East & Africa, Europe (Germany, United Kingdom, Italy, France, Spain, Netherlands, and Rest of Europe), and Central & South America. However, owing to the factors such as favorable reimbursement scenario for medical devices in the U.S. and Canada, rising awareness on patient-centric treatment for chronic disorders at patient’s homecare setting, rising prevalence of asthma in younger patients, and an increasing number of product launches in the country will support the dominance of the North American region in the market as of 2021. On the other hand, the market of Asia Pacific will be growing the fastest owing to the high prevalence of lung disorders and the rising number of patients suffering from Asthma.
MedTech, Ozocheck, SmartCare, BioPlus, BriutCare, Vectura, Contec Medical Systems Co.Ltd., FaceLake, YirDoc, Guangdong Delong Intelligent Technology CO., Ltd., Pulmotree Medical GMBH, and Vapo Health among others are the top players in the intelligent nebulizers market.
Please note: This is not an exhaustive list of companies profiled in the report.
We value your investment and offer free customization with every report to fulfil your exact research needs.
The Global Intelligent Nebulizers Market has been studied from the year 2019 till 2026. However, the CAGR provided in the report is from the year 2021 to 2026. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.
The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Intelligent Nebulizers Market.
The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.
Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.
Tailor made solutions just for you
80% of our clients seek made-to-order reports. How do you want us to tailor yours?